(Q36876003)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9254279%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9254279%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9254279%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

M D Simpson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9254279%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P Slater

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9254279%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J S Hellewell

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9254279%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9254279%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychopharmacology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9254279%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9254279%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9254279%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

133-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9254279%20AND%20SRC:MED&resulttype=core&format=json

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Activation of the glycine site in the NMDA receptor is necessary for the induction of LTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Myelination of cortical-hippocampal relays during late adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Increased Density of Glutamate-immunoreactive Vertical Processes in Superficial Laminae in Cingulate Cortex of Schizophrenic Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Neurotransmitter Receptors in Frontal Cortex of Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Schizophrenia--a brain disease? A critical review of structural and functional cerebral abnormality in the disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

NMDA‐induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5‐HT1A antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

History and pharmacology of PCP and PCP-related analogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Glutamate: A Neurotransmitter in Mammalian Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

21 January 2018

Neuronal birth and death

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Volumetric MRI measurements in bipolars compared with schizophrenics and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

NMDA-associated glycine binding site increases in schizophrenic brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Amelioration of negative symptoms in schizophrenia by glycine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to human cerebral cortical membranes: minimal changes in postmortem brains of chronic schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

A pet study of obligate carriers of the predisposition to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Interactions between antipsychotic and antihypertensive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Convergence and divergence of neurotransmitter action in human cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Medial frontal lobe overactivity in reality distortion syndrome during word generation: A pet study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Maturation of a central glutamatergic synapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

The effects of intraperitoneally administered phencyclidine on the central nervous system: behavioral and neurochemical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Propranolol as an adjunct to the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Volumetric MRI assessment of temporal lobe structures in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119701100206

10.1177/026988119701100206

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9254279%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference